首页> 外文期刊>British Journal of Pharmacology >Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I_2-imidazoline ligands
【24h】

Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I_2-imidazoline ligands

机译:咪唑烷和其他I_2-咪唑啉配体对阿片类药物引起的抗伤害感受的耐受性减弱以及对吗啡诱导的神经丝蛋白减少的保护作用

获取原文
获取原文并翻译 | 示例
       

摘要

Agmatie, the proposed endogenous ligand for imidazoline receptors, has been shown to attenuate tolerance to morphine-induced antinociception(Kolesnikov et al., 1996). The main aim of this study was to assess if idazoxan, an α_2-adrenoceptor antagonist that also interacts with imidazoline receptors, could also modulate opioid tolerance in rats and to establish which type of imidazoline receptors (or other receptors) are involved. Antinociceptive responses to opioid drugs were determined by the tail-flick test. The acute Administration of morphine(10 mg kg~-1, i.p., 30 min) or pentazocine (10 mg kg~-1), i.p., 30 min) resulted In marked increases in tail-flick latencies (TFLs).
机译:Agmatie是咪唑啉受体的拟议内源性配体,已显示出可减弱对吗啡诱导的抗伤害感受的耐受性(Kolesnikov等,1996)。这项研究的主要目的是评估是否也与咪唑啉受体相互作用的α_2-肾上腺素受体拮抗剂咪唑azo安也可以调节大鼠的阿片耐受性,并确定涉及哪种类型的咪唑啉受体(或其他受体)。通过甩尾试验确定对阿片类药物的镇痛反应。急性给予吗啡(10 mg kg〜-1,i.p.,30分钟)或喷他佐辛(10 mg kg〜-1),i.p.,30 min)导致甩尾潜伏期(TFLs)明显增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号